drug · oligonucleotide
patient view →prexigebersen
Phase 2updated 2mo agoby $BPTH BIO-PATH HOLDINGS, INC.🔗 ChEMBL
Phase 2community read0 votes
Oligonucleotide drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
targets
Growth factor receptor-bound protein 2 mRNA
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that